Mary Fisher, Chief Operating Officer at ACORDA THERAPEUTICS INC (ACOR), sold 40,000 shares at $16.01 ($642K) on 2006-11-06, disclosed to the SEC on 2006-11-08.
Scheduled sale ($642k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.96 | 600 | $10K | 1.5% |
| 2 | $15.98 | 200 | $3K | 0.5% |
| 3 | $15.99 | 1,900 | $30K | 4.7% |
| 4 | $16.00 | 2,800 | $45K | 7.0% |
| 5 | $16.01 | 1,200 | $19K | 3.0% |
| 6 | $16.02 | 2,203 |
| $35K |
| 5.5% |
| 7 | $16.03 | 8,797 | $141K | 22.0% |
| 8 | $16.04 | 3,400 | $55K | 8.5% |
| 9 | $16.05 | 3,611 | $58K | 9.0% |
| 10 | $16.06 | 3,900 | $63K | 9.8% |
| 11 | $16.07 | 4,959 | $80K | 12.4% |
| 12 | $16.08 | 1,900 | $31K | 4.8% |
| 13 | $16.09 | 1,230 | $20K | 3.1% |
| 14 | $16.10 | 300 | $5K | 0.8% |
| 15 | $16.11 | 1,000 | $16K | 2.5% |
| 16 | $16.12 | 700 | $11K | 1.8% |
| 17 | $16.13 | 100 | $2K | 0.3% |
| 18 | $16.14 | 400 | $6K | 1.0% |
| 19 | $16.15 | 200 | $3K | 0.5% |
| 20 | $16.17 | 300 | $5K | 0.8% |
| 21 | $16.20 | 300 | $5K | 0.8% |
| Total | $16.05 avg | 40,000 | $642K | 100% |
| Filing → |
| OVAS | BUY | 2015-09-11 | $101K | — | Filing → |
| ZLTQ | SELL | 2015-01-27 | $1.7M | — | Filing → |
| ACOR | SELL | 2007-07-05 | $133K | — | Filing → |